|
|
 |
Under s196E of the Veteransí Entitlements Act 1986 the Repatriation Commission,
an ex-service person or eligible dependant, or an ESO representing veterans or their
dependants, may ask the Repatriation Medical Authority to carry out an investigation
in respect of a particular kind of injury, disease or death, or to review the contents
of a Statement of Principles.
The following investigations previously commenced by the Authority have now been
concluded in 2000-2001:
1. goitre, particularly in relation to exposure to radiation
in Hiroshima;
2. malignant neoplasm of the bladder, particularly in relation to occupational exposure
to aromatic amines;
3. chloracne, particularly in relation to exposure to herbicides used in Vietnam,
namely 2,4-D, 2,4,5-T, cacodylic acid or picloram;
4. Hodgkinís disease, particularly in relation to exposure to herbicides used in
Vietnam, namely 2,4-D, 2,4,5-T, cacodylic acid or picloram;
5. malignant neoplasm of the lung, particularly in relation to exposure to herbicides
used in Vietnam, namely 2,4-D, 2,4,5-T, cacodylic acid or picloram;
6. porphyria cutanea tarda, particularly in relation to exposure to herbicides used
in Vietnam, namely 2,4-D, 2,4,5-T, cacodylic acid or picloram;
7. soft tissue sarcoma, particularly in relation to exposure to herbicides used in
Vietnam, namely 2,4-D, 2,4,5-T, cacodylic acid or picloram;
8. acquired cataract, particularly in relation to the required level of exposure
to solar radiation;
9. chronic solar skin damage, particularly in relation to the required level of exposure
to solar radiation;
10. malignant neoplasm of the lip epithelium, particularly in relation to the required
level of exposure to solar radiation;
11. non-melanotic malignant neoplasm of the skin, particularly in relation to the
required level of exposure to solar radiation;
12. pterygium, particularly in relation to the required level of exposure to solar
radiation;
13. aplastic anaemia;
14. chronic ulcerative colitis, particularly in relation to stress;
15. hypertension, particularly in relation to sleep apnoea;
16. malignant melanoma of the skin;
17. malignant neoplasm of the bile duct;
18. Alzheimerís disease;
19. dengue fever;
20. hypertension;
21. tinnitus;
22. deep vein thrombosis; and
23. chondromalacia patellae;
Investigations relating to the following were commenced
by the Authority in 2000-2001 and have now been concluded:
23. sensorineural hearing loss; and
24. otitic barotrauma
These investigations resulted in the revocation of existing
Statements of Principles and the determination of new Statements of Principles.
The following investigations gazetted in 1999/2000 have not been concluded as at
30 June 2001:
1. neuropathy;
2. osteoarthrosis;
3. motor neurone disease;
4. asthma;
5. carpal tunnel syndrome;
6. Gulf War syndrome;
7. mesangial IGA glomerulonenephritis;
8. bronchiectasis;
9. chronic pancreatitis;
10. giant cell arteritis;
11. psoriasis;
12. Meniereís disease; and
13. multiple chemical sensitivity.
The following investigations gazetted in 2000/2001 have not been concluded as at
30 June 2001:
14. chronic lymphoid leukaemia;
15. acute lymphoid leukaemia;
16. congenital pes planus;
17. acquired pes planus;
18. chronic gastritis;
19. lumbar spondylosis;
20. otitis externa;
21. inflammatory periodontal disease;
22. atherosclerotic peripheral vascular disease;
23. osteoporosis;
24. multiple sclerosis;
25. malignant neoplasm of the brain;
26. malignant neoplasm of the colon;
27. adenocarcinoma of the kidney;
28. carotid artery disease;
29. obesity;
30. malignant neoplasm of the anus;
31. open-angle glaucoma; and
32. macular degeneration.
In summary, as at 30 June 2001, the Authority has completed
25 investigations for the 12 month period and has 32 ongoing investigations.
This page last updated 10 April 2002.
|
